Discover 520 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Location: Louisville KY, Cleveland OH, Atlanta GA, Charlotte NC,
Sponsor: Zimmer Biomet
Sex: All
Age: 18+
Code: NCT05787821
Recruiting
Active & Responsive
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Louisville KY, Indianapolis IN, Pittsburgh PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
for
Cardiovascular Diseases, Metabolic Health
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 30 - 70
Code: NCT03670524
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Louisville KY, Lexington KY, Edgewood KY, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Louisville KY, New Albany IN, Cincinnati OH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis
for
Psoriasis
Location: Louisville KY, Saint Joseph MO, Doral FL, Murray UT
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 4 - 17
Code: NCT03988439
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC